AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Coherus BioSciences Statistics
Share Statistics
Coherus BioSciences has 115.21M shares outstanding. The number of shares has increased by 3.46% in one year.
Shares Outstanding | 115.21M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | 0% |
Owned by Institutions (%) | n/a |
Shares Floating | 110.59M |
Failed to Deliver (FTD) Shares | 249.69K |
FTD / Avg. Volume | 4.93% |
Short Selling Information
The latest short interest is 31.07M, so 26.97% of the outstanding shares have been sold short.
Short Interest | 31.07M |
Short % of Shares Out | 26.97% |
Short % of Float | 28.1% |
Short Ratio (days to cover) | 3.23 |
Valuation Ratios
The PE ratio is -1.32 and the forward PE ratio is -3.05.
PE Ratio | -1.32 |
Forward PE | -3.05 |
PS Ratio | 1.22 |
Forward PS | 0.6 |
PB Ratio | -1.62 |
P/FCF Ratio | -1.79 |
PEG Ratio | n/a |
Enterprise Valuation
Coherus BioSciences Inc. has an Enterprise Value (EV) of 691.51M.
EV / Earnings | -2.91 |
EV / Sales | 2.69 |
EV / EBITDA | -3.57 |
EV / EBIT | -3.4 |
EV / FCF | -3.95 |
Financial Position
The company has a current ratio of 1.43, with a Debt / Equity ratio of -2.49.
Current Ratio | 1.43 |
Quick Ratio | 1.24 |
Debt / Equity | -2.49 |
Total Debt / Capitalization | 167.3 |
Cash Flow / Debt | -0.36 |
Interest Coverage | -5.01 |
Financial Efficiency
Return on equity (ROE) is 1.23% and return on capital (ROIC) is -70.59%.
Return on Equity (ROE) | 1.23% |
Return on Assets (ROA) | -0.38% |
Return on Capital (ROIC) | -70.59% |
Revenue Per Employee | 1.09M |
Profits Per Employee | -1.01M |
Employee Count | 235 |
Asset Turnover | 0.41 |
Inventory Turnover | 2.6 |
Taxes
Income Tax | -380.00K |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -38.3% in the last 52 weeks. The beta is 0.69, so Coherus BioSciences 's price volatility has been higher than the market average.
Beta | 0.69 |
52-Week Price Change | -38.3% |
50-Day Moving Average | 1.28 |
200-Day Moving Average | 1.5 |
Relative Strength Index (RSI) | 48.85 |
Average Volume (20 Days) | 5.06M |
Income Statement
In the last 12 months, Coherus BioSciences had revenue of 257.24M and earned -237.89M in profits. Earnings per share was -2.53.
Revenue | 257.24M |
Gross Profit | 94.46M |
Operating Income | -203.20M |
Net Income | -237.89M |
EBITDA | -193.94M |
EBIT | -203.20M |
Earnings Per Share (EPS) | -2.53 |
Balance Sheet
The company has 102.89M in cash and 480.84M in debt, giving a net cash position of -377.95M.
Cash & Cash Equivalents | 102.89M |
Total Debt | 480.84M |
Net Cash | -377.95M |
Retained Earnings | -1.58B |
Total Assets | 505.00M |
Working Capital | 73.46M |
Cash Flow
In the last 12 months, operating cash flow was -174.88M and capital expenditures -286.00K, giving a free cash flow of -175.17M.
Operating Cash Flow | -174.88M |
Capital Expenditures | -286.00K |
Free Cash Flow | -175.17M |
FCF Per Share | -1.86 |
Margins
Gross margin is 36.72%, with operating and profit margins of -78.99% and -92.48%.
Gross Margin | 36.72% |
Operating Margin | -78.99% |
Pretax Margin | -92.62% |
Profit Margin | -92.48% |
EBITDA Margin | -75.39% |
EBIT Margin | -78.99% |
FCF Margin | -68.09% |
Dividends & Yields
CHRS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -174.48% |
FCF Yield | -104.86% |
Analyst Forecast
The average price target for CHRS is $7, which is 382.8% higher than the current price. The consensus rating is "Buy".
Price Target | $7 |
Price Target Difference | 382.8% |
Analyst Consensus | Buy |
Analyst Count | 4 |
Scores
Altman Z-Score | -3.93 |
Piotroski F-Score | 3 |